Finall A I, Olafsdottir R
University Hospital of Wales, Cardiff CF14 4XW, UK.
Cytopathology. 2009 Dec;20(6):367-74. doi: 10.1111/j.1365-2303.2009.00714.x.
To ascertain the positive predictive value of both ?glandular neoplasia (national standard code 6) and borderline change (national standard code 8) in glandular cells in liquid-based cervical cytology specimens in Cardiff and Vale NHS Trust and to outline the histological outcomes of these cases.
Eighty-nine liquid-based (Surepath) cervical cytology cases were retrospectively identified from a 2-year period (January 2005 to December 2006) and correlated with histopathological diagnoses.
Initial punch biopsy histology revealed 18 cases (21%) of cervical glandular intraepithelial neoplasia (CGIN). A further nine cases (10%) of CGIN were identified following local excision or hysterectomy. Ten cases of invasive malignancy were identified: four endocervical adenocarcinomas (all node negative, TNM stage T1b1), five endometrial adenocarcinomas and one squamous cell carcinoma. There were 10 with high-grade cervical intraepithelial neoplasia (CIN) alone. Women diagnosed with endometrial malignancy presented later with an average age of 64.6 years compared with 34.9 years for endocervical lesions. Taking high-grade CIN or worse as a positive outcome, the overall positive predictive value (PPV) of glandular abnormalities on cytology (both code 6 and 8) was 58.1% [95% confidence interval (CI) 47.8, 68.4]. PPV for borderline change in glandular cells alone was 24.1% (95% CI 8.5, 39.6) and for ?glandular neoplasia alone 75.4% (95% CI 64.3, 86.5).
With our interpretation of the classification, women with cytological diagnoses of glandular neoplasia of the cervix should initially be investigated by local resection rather than punch biopsy, and those with borderline change in glandular cells with repeat cytology.
确定在加的夫和韦尔国民保健服务信托基金(Cardiff and Vale NHS Trust)的液基宫颈细胞学标本中,腺上皮内瘤变(国家标准代码6)和临界改变(国家标准代码8)在腺细胞中的阳性预测值,并概述这些病例的组织学结果。
回顾性分析了2005年1月至2006年12月这两年间89例液基(Surepath)宫颈细胞学病例,并与组织病理学诊断结果进行关联。
最初的穿刺活检组织学检查显示18例(21%)宫颈腺上皮内瘤变(CGIN)。在局部切除或子宫切除术后又发现9例(10%)CGIN。确诊10例浸润性恶性肿瘤:4例宫颈管腺癌(均无淋巴结转移,TNM分期T1b1)、5例子宫内膜腺癌和1例鳞状细胞癌。另有10例仅为高级别宫颈上皮内瘤变(CIN)。诊断为子宫内膜恶性肿瘤的女性就诊时年龄较大,平均年龄为64.6岁,而宫颈管病变患者的平均年龄为34.9岁。将高级别CIN或更严重病变视为阳性结果,细胞学检查中腺细胞异常(代码6和8)的总体阳性预测值(PPV)为58.1% [95%置信区间(CI)47.8, 68.4]。仅腺细胞临界改变的PPV为24.1%(95% CI 8.5, 39.6),仅腺上皮内瘤变的PPV为75.4%(95% CI 64.3, 86.5)。
根据我们对分类的解读,宫颈腺上皮内瘤变细胞学诊断的女性最初应通过局部切除而非穿刺活检进行检查,而腺细胞有临界改变的女性应进行重复细胞学检查。